SAXENDA 18 MG/3 ML PEN

liraglutide
$87.1538per ML
High Outlier

Strength

6 mg/mL

Manufacturer

Novo Nordisk

NDC

00169280015

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

LIRAGLUTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA206321

On Market Since

12/31/2014

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price History

1W

0.0%

1M

-0.0%

3M

+0.1%

6M

+0.2%

1Y

+0.4%

3Y

+1.1%

5Y

+0.9%

All

+25.9%